Abstract
Non-alcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, and its prevalence is rising in parallel with worldwide increases in obesity and type 2 diabetes. However, the nature of this relationship remains debatable. In particular, it is unclear whether insulin resistance causes NAFLD or hepatic steatosis per se reduces insulin sensitivity. This review will examine data from recent studies on the link between insulin resistance and NAFLD, focusing on studies that have attempted to dissociate fatty liver and hepatic insulin resistance.
Keywords: Non-alcoholic fatty liver disease, Insulin resistance, Triglycerides, Free fatty acids, Steatosis, Mitochondrial dysfunction, Hepatic Fat, Hepatic Steatosis, Pathogenesis, Fat Accumulation, hyperinsulinemia, Lipid Dynamics, Intracellular Signaling, Hepatic Insulin Resistance, methionine and choline deficiency (MCD), very low density lipoprotein (VLDL), insulin receptor substrate (IRS), nuclear factor-kappaB (NFκB)
Current Diabetes Reviews
Title: Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease
Volume: 6 Issue: 5
Author(s): Khalida A. Lockman and Moffat J. Nyirenda
Affiliation:
Keywords: Non-alcoholic fatty liver disease, Insulin resistance, Triglycerides, Free fatty acids, Steatosis, Mitochondrial dysfunction, Hepatic Fat, Hepatic Steatosis, Pathogenesis, Fat Accumulation, hyperinsulinemia, Lipid Dynamics, Intracellular Signaling, Hepatic Insulin Resistance, methionine and choline deficiency (MCD), very low density lipoprotein (VLDL), insulin receptor substrate (IRS), nuclear factor-kappaB (NFκB)
Abstract: Non-alcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, and its prevalence is rising in parallel with worldwide increases in obesity and type 2 diabetes. However, the nature of this relationship remains debatable. In particular, it is unclear whether insulin resistance causes NAFLD or hepatic steatosis per se reduces insulin sensitivity. This review will examine data from recent studies on the link between insulin resistance and NAFLD, focusing on studies that have attempted to dissociate fatty liver and hepatic insulin resistance.
Export Options
About this article
Cite this article as:
A. Lockman Khalida and J. Nyirenda Moffat, Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease, Current Diabetes Reviews 2010; 6 (5) . https://dx.doi.org/10.2174/157339910793360879
DOI https://dx.doi.org/10.2174/157339910793360879 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
Current Molecular Medicine Recent Developments in Targeting Breast Cancer Stem Cells
Recent Patents on Regenerative Medicine Gender Disparity in Pediatric Diseases
Current Molecular Medicine The Influence of Traumatic Lumbar Puncture (TLP) on Outcome of Pediatric Patients
Current Pediatric Reviews Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations
Current Medicinal Chemistry Recent Advances for the Synthesis of Selenium-containing Small Molecules as Potent Antitumor Agents
Current Medicinal Chemistry Myeloma Cells and Their Interactions With the Bone Marrow Endothelial Cells
Current Immunology Reviews (Discontinued) Neuronal Generation from Somatic Stem Cells: Current Knowledge and Perspectives on the Treatment of Acquired and Degenerative Central Nervous System Disorders
Current Gene Therapy Pharmacokinetics and Disposition of Nanomedicine Using Biodegradable PEG/PCL Polymers as Drug Carriers
Current Drug Metabolism Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
Current Medicinal Chemistry TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery 1,5-Diaryl-3-oxo-1,4-pentadienes: A Case for Antineoplastics with Multiple Targets
Current Medicinal Chemistry Graphical Abstracts
Letters in Drug Design & Discovery Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Phytochemical and Pharmacological Insight on Sesamol: An Updated Review
Current Bioactive Compounds Targeted Drug Delivery: Trends and Perspectives
Current Drug Delivery Molecular Imaging of Matrix Metalloproteinases In Vivo Using Small Molecule Inhibitors for SPECT and PET
Current Medicinal Chemistry Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells
Current Medicinal Chemistry Microtubule Targeting Agents: A Benchmark in Cancer Therapy
Current Drug Therapy